-
Signature
-
Debra A. Cafaro By: /s/ Kenneth Hagan, Attorney-In-Fact
-
Issuer symbol
-
VTR
-
Transactions as of
-
29 Oct 2024
-
Transactions value $
-
-$52,385
-
Form type
-
4
-
Filing time
-
31 Oct 2024, 17:03:52 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
VTR |
Common Stock |
Options Exercise |
$7,995,093 |
+121,248 |
+12.29% |
$65.94 |
1,107,965 |
29 Oct 2024 |
Direct |
F1 |
| transaction |
VTR |
Common Stock |
Sale |
-$8,022,701 |
-121,248 |
-10.94% |
$66.17 |
986,717 |
29 Oct 2024 |
Direct |
F1, F2 |
| transaction |
VTR |
Common Stock |
Options Exercise |
$2,247,564 |
+34,085 |
+3.45% |
$65.94 |
1,020,802 |
30 Oct 2024 |
Direct |
F1 |
| transaction |
VTR |
Common Stock |
Sale |
-$2,272,341 |
-34,085 |
-3.34% |
$66.67 |
986,717 |
30 Oct 2024 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
VTR |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-121,248 |
-9.04% |
$0 |
1,220,432 |
29 Oct 2024 |
Common Stock |
121,248 |
$65.94 |
Direct |
F1, F4, F5 |
| transaction |
VTR |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-34,085 |
-2.79% |
$0 |
1,186,347 |
30 Oct 2024 |
Common Stock |
34,085 |
$65.94 |
Direct |
F1, F4, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: